Skip to main content
. 2022 Nov 2;92(3):189–196. doi: 10.1097/QAI.0000000000003123

TABLE 1.

Estimated HIV Incidence by Country and Estimate Method, and Percent Difference Between Methods, PHIAs, 2015–2019

n Testing History Estimate Biomarker Estimate Percent Difference
HIV Incidence (95% CI) CIR HIV Incidence (95% CI) CIR
Lesotho 2016 16,326 1.92 (1.74 to 2.10) 1.2 1.11 (0.68 to 1.52) 2.2 −42%
Eswatini 2016 11,784 1.24 (1.00 to 1.48) 1.5 1.14 (0.73 to 1.53) 2.1 −8%
Zambia 2016 27,069 0.59 (0.52 to 0.66) 1.3 0.61 (0.40 to 0.81) 2.0 3%
Zimbabwe 2015 25,309 0.55 (0.48 to 0.63) 1.3 0.40 (0.24 to 0.56) 2.3 −27%
Malawi 2015 24,063 0.43 (0.38 to 0.49) 1.3 0.37 (0.20 to 0.54) 2.7 −14%
Tanzania 2016 34,503 0.36 (0.32 to 0.41) 1.3 0.26 (0.15 to 0.36) 2.3 −27%
Namibia 2017 23,334 0.32 (0.26 to 0.38) 1.5 0.37 (0.18 to 0.55) 3.1 16%
Uganda 2016 31,661 0.28 (0.23 to 0.32) 1.4 0.41 (0.25 to 0.56) 2.2 46%
Cameroon 2017 28,737 0.18 (0.15 to 0.22) 1.5 0.24 (0.12 to 0.36) 3.1 33%
Rwanda 2018 32,468 0.07 (0.05 to 0.09) 1.8 0.08 (0.02 to 0.14) 6.4 14%
Ethiopia 2017 23,385 0.07 (0.04 to 0.09) 2.1 0.05 (0 to 0.10) 15.8 −29%
Cote d'Ivoire 2017 22,292 0.06 (0.02 to 0.09) 4.2 0.03 (0 to 0.07) 0.6 −50%

Incidence expressed as a percent. 95% confidence interval (CI) generated using the jackknife method. CIR, confidence interval ratio (upper/lower). Percent difference is the biomarker estimate minus testing history, divided by the testing history estimate, multiplied by 100. Negative percent difference indicates that the testing history estimate is larger than the biomarker estimate.